| NovoNorm 2 mg tablets EU/1/98/076/021 |
Repaglinide |
Novo Nordisk A/S |
— |
| NovoRapid 100 U/ml Solution for injection EU/1/99/119/001 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid FlexPen 100 U/ml Solution for injection EU/1/99/119/009-011 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid FlexTouch 100 U/ml Solution for injection EU/1/99/119/019 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid InnoLet 100 U/ml Solution for injection EU/1/99/119/012-014 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid Penfill 100 U/ml Solution for injection EU/1/99/119/003 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoRapid PumpCart 100 U/ml Solution for injection EU/1/99/119/024-025 |
Insulin aspart |
Novo Nordisk A/S |
— |
| NovoSeven (400 KIU) EU/1/96/006/007 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (100 KIU) EU/1/96/006/005 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (100 KIU) EU/1/96/006/009 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (250 KIU) EU/1/96/006/006 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (250 KIU) EU/1/96/006/010 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| Novoseven (400 KIU) EU/1/96/006/011 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (50 KIU) EU/1/96/006/004 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoSeven (50 KIU) EU/1/96/006/008 |
Eptacog alfa (activated) |
Novo Nordisk A/S |
— |
| NovoThirteen 2500 IU powder and solvent for solution for injection EU/1/12/775/001 |
Rfxiii drug substance |
Novo Nordisk A/S |
— |
| Olmesartan Krka 10 mg film-coated tablets PA1347/060/001 |
Olmesartan medoxomil |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan Krka 20 mg film-coated tablets PA1347/060/002 |
Olmesartan medoxomil |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan Krka 40 mg film-coated tablets PA1347/060/003 |
Olmesartan medoxomil |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/10 mg/25 mg film-coated tablets PA1347/096/005 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Not marketed |
| Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/5 mg/12.5 mg film-coated tablets PA1347/096/002 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Not marketed |
| Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/5 mg/25 mg film-coated tablets PA1347/096/003 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Not marketed |
| Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 20 mg/5 mg/12.5 mg film-coated tablets PA1347/096/001 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Not marketed |
| Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/10 mg/12.5 mg film-coated tablets PA1347/096/004 |
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Not marketed |
| Olmesartan/Amlodipine Krka 20 mg/5 mg film-coated tablets PA1347/075/001 |
Olmesartan medoxomil, Amlodipine |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan/Amlodipine Krka 40 mg/10 mg film-coated tablets PA1347/075/003 |
Olmesartan medoxomil, Amlodipine |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan/Amlodipine Krka 40 mg/5 mg film-coated tablets PA1347/075/002 |
Olmesartan medoxomil, Amlodipine |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan/Hydrochlorothiazide Krka 20 mg/12.5 mg film-coated tablets PA1347/061/001 |
Olmesartan medoxomil, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan/Hydrochlorothiazide Krka 20 mg/25 mg film-coated tablets PA1347/061/002 |
Olmesartan medoxomil, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan/Hydrochlorothiazide Krka 40 mg/12.5 mg film-coated tablets PA1347/061/003 |
Olmesartan medoxomil, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Marketed |
| Olmesartan/Hydrochlorothiazide Krka 40 mg/25 mg film-coated tablets PA1347/061/004 |
Olmesartan medoxomil, Hydrochlorothiazide |
KRKA, d.d., Novo mesto |
Marketed |
| Oprymea 0.088 mg tablets EU/1/08/469/1-5 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.18 mg tablets EU/1/08/469/6-10 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.26 mg prolonged-release tablets EU/1/08/469/026-029 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.35 mg tablets EU/1/08/469/11-15 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.52 mg prolonged-release tablets EU/1/08/469/030-033 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.7 mg tablets EU/1/08/469/16-20 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 1.05 mg prolonged-release tablets EU/1/08/469/034-037 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 1.1 mg tablets EU/1/08/469/21-25 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 1.57 mg prolonged-release tablets EU/1/08/469/038-041 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 2.1 mg prolonged-release tablets EU/1/08/469/042-045 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 2.62 mg prolonged-release tablets EU/1/08/469/046-049 |
Pramipexole dihydrochloride monohydrate |
KRKA, d.d., Novo mesto |
— |
| Oprymea 3.15 mg prolonged-release tablets EU/1/08/469/050-053 |
Pramipexole dihydrochloride monohydrate |
KRKA, d.d., Novo mesto |
— |
| Ozempic 0.25 mg solution for injection in pre-filled pen EU/1/17/1251/002 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 0.5 mg solution for injection in pre-filled pen EU/1/17/1251/003-004 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 0.5 mg solution for injection in pre-filled pen EU/1/17/1251/012-013 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 1 mg solution for injection in pre-filled pen EU/1/17/1251/005-006 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ozempic 2 mg solution for injection in pre-filled pen EU/1/17/1251/010-011 |
Semaglutide |
Novo Nordisk A/S |
— |
| Paglitaz EU/1/11/721/001-007 |
Pioglitazone hydrochloride |
KRKA, d.d., Novo mesto |
— |
| Paglitaz EU/1/11/721/008-014 |
Pioglitazone hydrochloride |
KRKA, d.d., Novo mesto |
— |